Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors

M Federico, L Bagella - BioMed Research International, 2011 - Wiley Online Library
The human genome is epigenetically organized through a series of modifications to the
histone proteins that interact with the DNA. In cancer, many of the proteins that regulate …

[PDF][PDF] Histone deacetylase inhibitors in cancer therapy. A review

J Hrabeta, M Stiborova, V Adam, R Kizek… - Biomedical …, 2014 - biomed.papers.upol.cz
Background. Despite recent success toward discovery of more effective anticancer drugs,
chemoresistance remains a major cause of treatment failure. There is emerging evidence …

[HTML][HTML] Histone deacetylases and their inhibitors in cancer epigenetics

KN Hassell - Diseases, 2019 - mdpi.com
Histone deacetylases (HDAC) and histone deacetylase inhibitors (HDACi) have greatly
impacted the war on cancer. Their role in epigenetics has significantly altered the …

Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents

A Budillon, E Di Gennaro, F Bruzzese… - Recent patents on …, 2007 - ingentaconnect.com
Epigenetics as well as post-translational modifications of proteins are emerging as novel
attractive targets for anti-cancer therapy. Histone acetyltransferases (HATs) and histone …

Histone deacetylase inhibitors, anticancerous mechanism and therapy for gastrointestinal cancers

JY Fang - Journal of gastroenterology and hepatology, 2005 - Wiley Online Library
Histone acetylation regulates gene transcription. Histone acetylation is a reversible process:
histone acetyltransferases (HAT) transfer the acetyl moiety from acetyl coenzyme A to the …

[HTML][HTML] Histone deacetylases and histone deacetylase inhibitors: molecular mechanisms of action in various cancers

M Sanaei, F Kavoosi - Advanced biomedical research, 2019 - journals.lww.com
Epigenetic modifications such as histone modification play an important role in
tumorigenesis. There are several evidence that histone deacetylases (HDACs) play a key …

Role of histone deacetylase inhibitors in the treatment of cancer

S Mei, AD Ho, U Mahlknecht - … journal of oncology, 2004 - spandidos-publications.com
Acetylation and deacetylation of nucleosomal histones play an important role in the
modulation of chromatin structure, chromatin function and in the regulation of gene …

[HTML][HTML] Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment

D Schizas, A Mastoraki, L Naar, E Spartalis… - World Journal of …, 2018 - ncbi.nlm.nih.gov
Esophageal cancer (EC) presents a high mortality rate, mainly due to its aggressive nature.
Squamous cell carcinoma is the most common histological type worldwide, though, a …

Histone deacetylase inhibitors–a new tool to treat cancer

R Somech, S Izraeli, AJ Simon - Cancer treatment reviews, 2004 - Elsevier
Transcriptional regulation in eukaryotes is a multilevel hierarchical process. It is becoming
clear that higher-order chromatin structure, occurring via modifications of histones in their …

Targeting histone deacetylases for the treatment of cancer and inflammatory diseases

L Huang - Journal of cellular physiology, 2006 - Wiley Online Library
Histone deacetylases (HDACs) are involved in chromatin remodeling and modification of
nonhistone transcription regulatory proteins, thus modulating the expression of genes …